ArticleOncotarget2016

Predicting the cell death responsiveness and sensitization of glioma cells to TRAIL and temozolomide.

Birgit C Weyhenmeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.